Open AccessP120 (0086) OUTCOMES AND TOXICITIES AFTER BRENTUXIMAB VEDOTIN (BV) MAINTENANCE IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENT EXPOSED TO BV PRIOR TO AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT
Publication year - 2018
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000547964.15415.bd
Subject(s) - brentuximab vedotin , medicine , oncology , refractory (planetary science) , lymphoma , hematopoietic stem cell transplantation , hodgkin lymphoma , transplantation , biology , astrobiology